COMMUNIQUÉS West-GlobeNewswire

-
Nuvectra Completes 3,000 U.S. Algovita® SCS Implantations
06/12/2018 -
Ovid Therapeutics Announces Plans to Move into a Phase 3 Trial in Pediatric Patients Based on End-of-Phase 2 Meeting for OV101 in Angelman Syndrome
06/12/2018 -
Rhythm Pharmaceuticals to Host Key Opinion Leader Symposium on MC4R Pathway and Patient Experience with Rare Genetic Disorders of Obesity, Including Bardet-Biedl Syndrome
06/12/2018 -
Avinger Announces Commercial Launch in Australia
06/12/2018 -
BioSig Technologies To Commence First–in-Human Studies at Mayo Clinic
06/12/2018 -
Chembio’s French Partner AAZ-LMB Wins Prix Galien International for Best Medical Technology with autotest VIH®
06/12/2018 -
VBI Vaccines Enters into License and Collaboration Agreement with Brii Biosciences for up to $129 Million plus Royalties to Develop a Functional Cure for Hepatitis B
06/12/2018 -
Rexahn Pharmaceuticals Streamlines Operations and Provides Update on Pipeline
06/12/2018 -
Diamond CBD Goes Funny In New CBD Educational Awareness Ad Campaign
06/12/2018 -
Uptick Newswire’s Stock Day Podcast Features Richard Van Kirk, Pro-Dex, Inc.’s CEO, to talk about the Growing Success of The Company and Plans to Keep up The Momentum
06/12/2018 -
NASA Deploys Medigus’ micro ScoutCam™ Miniature HD Camera During Robotic Refueling Mission
06/12/2018 -
Kiniksa Provides Update on U.S. FDA Review of Investigational New Drug Application for Mavrilimumab in Giant Cell Arteritis
06/12/2018 -
NanoVibronix Announces Publication of Study Measuring the Effect of Surface Acoustic Waves on Bacterial Load and Preventing Catheter-Associated Urinary Tract Infections
06/12/2018 -
Daré Bioscience, Inc. Announces Licensing and Global Rights to Novel Phase III Product Candidate for the Treatment of Bacterial Vaginosis
06/12/2018 -
LogicBio Therapeutics Appoints Richard Moscicki, M.D., and Michael Wyzga to Board of Directors
06/12/2018 -
Arch Therapeutics Provided Corporate Update at the 11th Annual LD Micro Main Event
06/12/2018 -
Brain Scientific Announces Successful Commercialization & First Purchase Order Shipment Of NeuroCap
06/12/2018 -
Auris Medical Announces Acquisition of Orphan Drug Designation and Secures Rights to In-License Additional Patents Related to Betahistine
06/12/2018 -
Pain Therapeutics Announces Initiation of a Phase II Study in Alzheimer’s Disease
06/12/2018
Pages